1. Home
  2. KURA vs BBW Comparison

KURA vs BBW Comparison

Compare KURA & BBW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KURA
  • BBW
  • Stock Information
  • Founded
  • KURA 2014
  • BBW 1997
  • Country
  • KURA United States
  • BBW United States
  • Employees
  • KURA N/A
  • BBW N/A
  • Industry
  • KURA Biotechnology: Biological Products (No Diagnostic Substances)
  • BBW Recreational Games/Products/Toys
  • Sector
  • KURA Health Care
  • BBW Consumer Discretionary
  • Exchange
  • KURA Nasdaq
  • BBW Nasdaq
  • Market Cap
  • KURA 492.9M
  • BBW 464.1M
  • IPO Year
  • KURA N/A
  • BBW 2004
  • Fundamental
  • Price
  • KURA $5.64
  • BBW $40.90
  • Analyst Decision
  • KURA Strong Buy
  • BBW Strong Buy
  • Analyst Count
  • KURA 12
  • BBW 4
  • Target Price
  • KURA $24.50
  • BBW $50.50
  • AVG Volume (30 Days)
  • KURA 1.2M
  • BBW 221.6K
  • Earning Date
  • KURA 05-01-2025
  • BBW 05-29-2025
  • Dividend Yield
  • KURA N/A
  • BBW 2.15%
  • EPS Growth
  • KURA N/A
  • BBW 4.11
  • EPS
  • KURA N/A
  • BBW 3.80
  • Revenue
  • KURA $67,991,000.00
  • BBW $496,404,000.00
  • Revenue This Year
  • KURA $171.90
  • BBW $5.54
  • Revenue Next Year
  • KURA $60.51
  • BBW $3.77
  • P/E Ratio
  • KURA N/A
  • BBW $10.76
  • Revenue Growth
  • KURA N/A
  • BBW 2.12
  • 52 Week Low
  • KURA $5.41
  • BBW $23.63
  • 52 Week High
  • KURA $23.48
  • BBW $48.23
  • Technical
  • Relative Strength Index (RSI)
  • KURA 40.55
  • BBW 59.60
  • Support Level
  • KURA $5.56
  • BBW $40.53
  • Resistance Level
  • KURA $6.51
  • BBW $42.56
  • Average True Range (ATR)
  • KURA 0.42
  • BBW 1.44
  • MACD
  • KURA 0.02
  • BBW 0.22
  • Stochastic Oscillator
  • KURA 13.22
  • BBW 70.05

About KURA Kura Oncology Inc.

Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signaling pathways to drive the progression of various cancers. The company has a product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. Geographically operation of the group is carried through the United States.

About BBW Build-A-Bear Workshop Inc.

Build-A-Bear Workshop Inc is a U.S.-based specialty retailer of customized stuffed animals and related products. The company operates through three segments. Its Direct-to-consumer segment with key revenue, includes the operating activities of corporately-managed locations and other retail delivery operations in the U.S., Canada, China, Denmark, Ireland, and the U.K., including the company's e-commerce sites and temporary stores. The international franchising segment includes the licensing activities of the company's franchise agreements with store locations in Europe, Asia, Australia, the Middle East, and Africa. The commercial segment includes the transactions with other businesses, mainly comprised of licensing the intellectual properties for third-party use and wholesale activities.

Share on Social Networks: